A higher frequency of CD14+CD169+ monocytes/macrophages in patients with colorectal cancer

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Li, Chenguang ^a   Luo, Xiaofan ^a   Lin, Yuyang ^a   Tang, Xiuqi ^a   Ling, Limian ^a   Wang, Lei ^a   Jiang, Yanfang ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CD14 ANTIGEN; CD163 ANTIGEN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; SIALOADHESIN; LEUKOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER STAGING; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LAMINA PROPRIA; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MIDDLE AGED; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MONOCYTE; MONONUCLEAR CELL; TUMOR ASSOCIATED LEUKOCYTE; CANCER GRADING; CASE CONTROL STUDY; COLORECTAL TUMOR; IMMUNOLOGY; IMMUNOPHENOTYPING; INTESTINE MUCOSA; LEUKOCYTE COUNT; MACROPHAGE; METABOLISM; PATHOLOGY; PHENOTYPE;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD14; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTESTINAL MUCOSA; LEUKOCYTE COUNT; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; NEOPLASM GRADING; NEOPLASM STAGING; PHENOTYPE; SIALIC ACID BINDING IG-LIKE LECTIN 1;

EID: 84949815661     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0141817     Document Type: Article

References (45)

1. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA: a cancer journal for clinicians. 2014; 64(2):104-17.
2. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420(6917):860-7. PMID: 12490959
3. Atsumi T, Singh R, Sabharwal L, Bando H, Meng J, Arima Y, et al. Inflammation amplifier, a new paradigm in cancer biology. Cancer research. 2014; 74(1):8-14. doi: 10.1158/0008-5472.CAN-13-2322 PMID: 24362915
4. Coffelt SB, de Visser KE. Cancer: Inflammation lights the way to metastasis. Nature. 2014; 507 (7490):48-9. doi: 10.1038/nature13062 PMID: 24572360
5. Mariani F, Sena P, Roncucci L. Inflammatory pathways in the early steps of colorectal cancer development. World journal of gastroenterology: WJG. 2014; 20(29):9716-31. doi: 10.3748/wjg.v20.i29.9716 PMID: 25110410
6. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008; 454 (7203):436-44. doi: 10.1038/nature07205 PMID: 18650914
7. Pages F, Galon J, Dieu-Nosjean MC, Tartour E, Sautes-Fridman C, Fridman WH. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene. 2010; 29(8):1093-102. doi: 10.1038/onc.2009.416 PMID: 19946335
8. Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Critical reviews in oncology/hematology. 2008; 66(1):1-9. PMID: 17913510
9. Gentek R, Molawi K, Sieweke MH. Tissue macrophage identity and self-renewal. Immunological reviews. 2014; 262(1):56-73. doi: 10.1111/imr.12224 PMID: 25319327
10. Bain CC, Scott CL, Uronen-Hansson H, Gudjonsson S, Jansson O, et al. (2013) Resident and proinflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol 6: 498-510. doi: 10.1038/mi.2012.89 PMID: 22990622
11. Zigmond E, Varol C, Farache J, Elmaliah E, Satpathy AT, Friedlander G, et al. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity. 2012; 37(6):1076-90. doi: 10.1016/j.immuni.2012.08.026 PMID: 23219392
12. Mills CD. M1 and M2 Macrophages: Oracles of Health and Disease. Critical reviews in immunology. 2012; 32(6):463-88. PMID: 23428224
13. Gundra UM, Girgis NM, Ruckerl D, Jenkins S, Ward LN, Kurtz ZD, et al. Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct. Blood. 2014; 123(20):e110-22. doi: 10.1182/blood-2013-08-520619 PMID: 24695852
14. Erreni M, Mantovani A, Allavena P. Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer. Cancer microenvironment: official journal of the International Cancer Microenvironment Society. 2011; 4(2):141-54.
15. Kurahara H, Shinchi H, Mataki Y, Maemura K, Noma H, Kubo F, et al. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. The Journal of surgical research. 2011; 167(2): e211-9. doi: 10.1016/j.jss.2009.05.026 PMID: 19765725
16. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. Journal of immunology. 2000; 164(12):6166-73.
17. Sica A, Saccani A, Bottazzi B, Polentarutti N, Vecchi A, van Damme J, et al. Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages. Journal of immunology. 2000; 164(2):762-7.
18. Kamada N, Hisamatsu T, Okamoto S, Chinen H, Kobayashi T, Sato T, et al. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. The Journal of clinical investigation. 2008; 118(6):2269-80. doi: 10.1172/JCI34610 PMID: 18497880
19. Smith PD, Smythies LE, Shen R, Greenwell-Wild T, Gliozzi M, Wahl SM. Intestinal macrophages and response to microbial encroachment. Mucosal immunology. 2011; 4(1):31-42. doi: 10.1038/mi.2010. 66 PMID: 20962772
20. Marmey B, Boix C, Barbaroux JB, Dieu-Nosjean MC, Diebold J, Audouin J, et al. CD14 and CD169 expression in human lymph nodes and spleen: specific expansion of CD14+CD169-monocyte-derived cells in diffuse large B-cell lymphomas. Human pathology. 2006; 37(1):68-77. PMID: 16360418
21. Tang Y, Hua SC, Qin GX, Xu LJ, Jiang YF. Different subsets of macrophages in patients with new onset tuberculous pleural effusion. PloS one. 2014; 9(2):e88343. doi: 10.1371/journal.pone.0088343 PMID: 24520370
22. Hartnell A. Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations. Blood. 2001; 97(1):288-96. PMID: 11133773
23. York MR, Nagai T, Mangini AJ, Lemaire R, van Seventer JM, Lafyatis R. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists. Arthritis and rheumatism. 2007; 56(3):1010-20. PMID: 17328080
24. Biesen R, Demir C, Barkhudarova F, Grun JR, Steinbrich-Zollner M, Backhaus M, et al. Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus. Arthritis and rheumatism. 2008; 58(4):1136-45. doi: 10.1002/art.23404 PMID: 18383365
25. Xiong YS, Cheng Y, Lin QS, Wu AL, Yu J, Li C, et al. Increased expression of Siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis. Rheumatology. 2014; 53(2):250-9. doi: 10.1093/rheumatology/ket342 PMID: 24196391
26. De Palma M, Lewis CE. Macrophage regulation of tumor responses to anticancer therapies. Cancer cell. 2013; 23(3):277-86. doi: 10.1016/j.ccr.2013.02.013 PMID: 23518347
27. Mantovani A, Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Current opinion in immunology. 2010; 22(2):231-7. doi: 10.1016/j.coi.2010.01.009 PMID: 20144856
28. Ohnishi K, Komohara Y, Saito Y, Miyamoto Y, Watanabe M, Baba H, et al. CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma. Cancer science. 2013; 104(9):1237-44. doi: 10.1111/cas.12212 PMID: 23734742
29. Hiemstra IH, Beijer MR, Veninga H, Vrijland K, Borg EGF, Olivier BJ, et al. The identification and developmental requirements of colonic CD169+macrophages. Immunology. 2014; 142(2):269-78. PMID: 24883436
30. Edge S, Byrd DR, Compton CC, Fritz AG, FL G. AJCC cancer staging handbook from the AJCC cancer stagnig manual, 7th edn. 2010:p63-p79.
31. Nordenvall C, Nyren O, YeW(2006) Elevated anal squamous cell carcinoma risk associated with benign inflammatory anal lesions. Gut 55: 703-707. PMID: 16299038
32. Weigmann B, Tubbe I, Seidel D, Nicolaev A, Becker C, Neurath MF. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nature protocols. 2007; 2(10):2307-11. PMID: 17947970
33. Meng F, Lowell CA (1997) Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn. J Exp Med 185: 1661-1670. PMID: 9151903
34. Prasse A, Germann M, Pechkovsky DV, Markert A, Verres T, et al. (2007) IL-10-producing monocytes differentiate to alternatively activated macrophages and are increased in atopic patients. J Allergy Clin Immunol 119: 464-471. PMID: 17291860
35. Buckner CM, Calderon TM, Willams DW, Belbin TJ, Berman JW. Characterization of monocyte maturation/ differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: implications for NeuroAIDS. Cellular immunology. 2011; 267(2):109-23. doi: 10.1016/j.cellimm. 2010.12.004 PMID: 21292246
36. Schenk M, Bouchon A, Birrer S, Colonna M, Mueller C (2005) Macrophages expressing triggering receptor expressed on myeloid cells-1 are underrepresented in the human intestine. J Immunol 174: 517-524. PMID: 15611278
37. Oliveira Miranda D, Soares de Lima TA, Ribeiro Azevedo L, Feres O, Ribeiro da Rocha JJ, Pereira-da-Silva G. Proinflammatory cytokines correlate with depression and anxiety in colorectal cancer patients. BioMed research international. 2014; 2014:739650. doi: 10.1155/2014/739650 PMID: 25309921
38. Miteva LD, Stanilov NS, Deliysky TS, Stanilova SA. Significance of-1082A/G polymorphism of IL10 gene for progression of colorectal cancer and IL-10 expression. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014; 35(12):12655-64.
39. Herszenyi L, Farinati F, Cardin R, Istvan G, Molnar LD, Hritz I, et al. Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer. BMC cancer. 2008; 8:194. doi: 10.1186/1471-2407-8-194 PMID: 18616803
40. Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. The Journal of clinical investigation. 2007; 117(5):1155-66. PMID: 17476345
41. Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-tomacrophage differentiation and polarization: new molecules and patterns of gene expression. Journal of immunology. 2006; 177(10):7303-11.
42. Ikezumi Y, Suzuki T, Hayafuji S, Okubo S, Nikolic-Paterson DJ, Kawachi H, et al. The sialoadhesin (CD169) expressing a macrophage subset in human proliferative glomerulonephritis. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association. 2005; 20(12):2704-13.
43. Hagemann T, Wilson J, Burke F, Kulbe H, Li NF, Pluddemann A, et al. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. Journal of immunology. 2006; 176(8):5023-32.
44. Mills CD, Thomas AC, Lenz LL, Munder M. Macrophage: SHIP of Immunity. Frontiers in immunology. 2014; 5:620. doi: 10.3389/fimmu.2014.00620 PMID: 25538705
45. Cook J, Hagemann T. Tumour-associated macrophages and cancer. Current opinion in pharmacology. 2013; 13(4):595-601. doi: 10.1016/j.coph.2013.05.017 PMID: 23773801